Literature DB >> 9285563

Elevated expression of eIF4E and FGF-2 isoforms during vascularization of breast carcinomas.

C A Nathan1, P Carter, L Liu, B D Li, F Abreo, A Tudor, S G Zimmer, A De Benedetti.   

Abstract

The translation initiation factor eIF4E is a novel protooncogene found over expressed in most breast carcinomas (Kerekatte et al., 1995), but the pathology where this elevation is initially manifested and its possible role in cancer progression are unknown. We report that eIF4E is markedly increased in vascularized malignant ductules of invasive carcinomas, whereas necrotic and avascular ductal carcinomas in situ display significantly lower levels. eIF4E facilitates the synthesis of FGF-2, a powerful tumor angiogenic factor. Conversely, reducing eIF4E with antisense RNA in MDA-435 cells suppresses their tumorigenic and angiogenic properties, consistent with loss of FGF-2 synthesis. These findings suggest a causal role for eIF4E in tumor vascularization.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9285563     DOI: 10.1038/sj.onc.1201272

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  39 in total

1.  In sickness and in health: the importance of translational regulation.

Authors:  P R Reynolds
Journal:  Arch Dis Child       Date:  2002-05       Impact factor: 3.791

2.  The proline-rich homeodomain protein, PRH, is a tissue-specific inhibitor of eIF4E-dependent cyclin D1 mRNA transport and growth.

Authors:  Ivan Topisirovic; Biljana Culjkovic; Natalie Cohen; Jacqueline M Perez; Lucy Skrabanek; Katherine L B Borden
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

Review 3.  A review of the association between osteosarcoma metastasis and protein translation.

Authors:  T S Osborne; C Khanna
Journal:  J Comp Pathol       Date:  2012-01-31       Impact factor: 1.311

Review 4.  Translational Control in Cancer.

Authors:  Nathaniel Robichaud; Nahum Sonenberg; Davide Ruggero; Robert J Schneider
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-07-01       Impact factor: 10.005

5.  The mitogen-activated protein kinase signal-integrating kinase Mnk2 is a eukaryotic initiation factor 4E kinase with high levels of basal activity in mammalian cells.

Authors:  G C Scheper; N A Morrice; M Kleijn; C G Proud
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

6.  Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): potential role of cyclin D1.

Authors:  S Pervin; R Singh; G Chaudhuri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

7.  Clinical outcome in stage I to III breast carcinoma and eIF4E overexpression.

Authors:  B D Li; J C McDonald; R Nassar; A De Benedetti
Journal:  Ann Surg       Date:  1998-05       Impact factor: 12.969

8.  Gamma interferon and cadmium treatments modulate eukaryotic initiation factor 4E-dependent mRNA transport of cyclin D1 in a PML-dependent manner.

Authors:  Ivan Topisirovic; Allan D Capili; Katherine L B Borden
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

Review 9.  The oncogene eIF4E: using biochemical insights to target cancer.

Authors:  Martin Carroll; Katherine L B Borden
Journal:  J Interferon Cytokine Res       Date:  2013-03-08       Impact factor: 2.607

10.  Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer.

Authors:  Biljana Culjkovic; Katherine L Borden
Journal:  J Oncol       Date:  2009-12-13       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.